why choose us

First received: June 15, 2023

Clinical Trial: Study Evaluating SHEN26 Capsule in Patients With Mild to Moderate COVID-19

Study Status: Completed

Recruit Status: RECRUITING

Condition: COVID-19

Study Type: INTERVENTIONAL


Official Title: A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of SHEN26 Capsule in Adult Participants With Mild to Moderate COVID-19

Brief Summary: This is a multicenter, randomized, double-blind, placebo-parallel-controlled phase III clinical trial.It is designed to evaluate the efficacy and safety of SHEN26 capsules in Chinese adult patients with mild to moderate COVID-19

Read more